Last reviewed · How we verify

NCT04448548

Possible Roles of MDW in Infection Management in Emergency Care

Completed Last updated 26 June 2020
What this trial tests

trial testing blood sample taking in Infection in 300 participants. Completed in 31 January 2020.

Timeline
1 September 2019
Primary endpoint
31 January 2020
31 January 2020

Quick facts

Lead sponsorSzeged University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date1 September 2019
Primary completion31 January 2020
Estimated completion31 January 2020
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

Szeged University

Who can join

18 and older, any sex, with Infection or Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective study to determine the potential value of MDW among other biomarkers in the diagnosis of infection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infection

Currently open trials in the same condition.

Other Szeged University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04448548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing